These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3920216)

  • 1. Binding and activation of plasminogen on the platelet surface.
    Miles LA; Plow EF
    J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen interaction with platelets: the importance of carboxyterminal lysines.
    Horne MK; Merryman PK; Cullinane AM
    Thromb Res; 2005; 116(6):499-507. PubMed ID: 15894352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the binding of human tissue-type plasminogen activator to platelets.
    Vaughan DE; Mendelsohn ME; Declerck PJ; Van Houtte E; Collen D; Loscalzo J
    J Biol Chem; 1989 Sep; 264(27):15869-74. PubMed ID: 2550424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator.
    Lenich C; Liu JN; Gurewich V
    Blood; 1997 Nov; 90(9):3579-86. PubMed ID: 9345041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.
    Stricker RB; Wong D; Shiu DT; Reyes PT; Shuman MA
    Blood; 1986 Jul; 68(1):275-80. PubMed ID: 2941084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
    Plow EF; Freaney DE; Plescia J; Miles LA
    J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen interacts with human platelets through two distinct mechanisms.
    Miles LA; Ginsberg MH; White JG; Plow EF
    J Clin Invest; 1986 Jun; 77(6):2001-9. PubMed ID: 3086385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator.
    Ouimet H; Freedman JE; Loscalzo J
    Biochemistry; 1994 Mar; 33(10):2970-6. PubMed ID: 8130211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-binding domains of plasminogen and their function in plasma.
    Miles LA; Dahlberg CM; Plow EF
    J Biol Chem; 1988 Aug; 263(24):11928-34. PubMed ID: 3403557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes.
    Jiang Y; Pannell R; Liu JN; Gurewich V
    Blood; 1996 Apr; 87(7):2775-81. PubMed ID: 8639894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation.
    Ezratty A; Simon DI; Loscalzo J
    Biochemistry; 1993 May; 32(17):4628-33. PubMed ID: 8485140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
    Kuusela P; Saksela O
    Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
    Silverstein RL; Harpel PC; Nachman RL
    J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.